Running Point Capital Advisors, LLC - NABRIVA THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637113. A total of 29 filers reported holding NABRIVA THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Running Point Capital Advisors, LLC ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q2 2022$2,000
-50.0%
10,0000.0%0.00%
-50.0%
Q1 2022$4,000–10,000–0.00%–
 Download
Other shareholders

There were no reported owners of NABRIVA THERAPEUTICS PLC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of NABRIVA THERAPEUTICS PLC shareholders